Inclusion Criteria:  Adults 18 years and older Vitiligo patients already on treatment who demonstrate stable disease (have noted some repigmentation in hair bearing areas) Willingness to participate in the study Willingness to undergo biopsies of full-thickness skin tissue from areas without vitiligo and having them transplanted into areas with vitiligo Informed consent agreement signed by the subject  Exclusion Criteria:  Adults unable to consent (adults lacking capacity) Individuals who are not yet adults (infants, children, teenagers) Pregnant women Prisoners Unable to return for follow-up visits Infection or other dermatologic condition different than vitiligo in the area to be treated Personal or family history of keloid formation Known allergies to injectable lidocaine or other topical anesthetics Systemic immunosuppressive medication (oral corticosteroids) within prior 4 weeks Topical steroids at planned recipient site within the prior 1 week Individuals who are unwilling to discontinue topical steroids at recipient site Prescription or over-the-counter medication or cosmetics containing: retinoids, glycolic acid, salicylic acid, topical steroids at the site of treatment or oral corticosteroids, or any other remedies that might affect the healing process. Non-medicated moisturizers are allowed. Co-existent inflammatory skin disease Any other condition or laboratory value that would, in the professional opinion of the investigators, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.